GlassScriptPhysician profile
Heather A Curtis
NPI 1609244193
$57,326.96
in general payments reported to CMS, 2019-2025
29 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.41 · 2020: $106 · 2021: $33.99 · 2022: $341 · 2023: $1,500 · 2024: $15K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Consulting Fee: $8,574 · Travel and Lodging: $3,398 · Food and Beverage: $2,095 · Education: $67.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,665.00 |
| Consulting Fee | $8,574.00 |
| Travel and Lodging | $3,398.03 |
| Food and Beverage | $2,094.82 |
| Education | $67.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $32,656.50 | 2022-2025 | Dupixent |
| Genzyme Corporation | $23,616.65 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $131.24 | 2022-2025 | Keytruda |
| Aerin Medical INC. | $84.60 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $81.34 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $67.99 | 2025 | |
| Amgen INC. | $66.26 | 2022 | |
| Janssen Biotech, INC. | $63.09 | 2021-2024 | Tecvayli, Talvey, Darzalex |
| Taiho Oncology, INC. | $51.78 | 2020-2023 | |
| Medtronic USA, INC. | $46.41 | 2019 | |
| Emd Serono, INC. | $42.66 | 2023-2024 | Bavencio |
| Optinose US, INC. | $39.70 | 2023-2024 | |
| Acclarent, INC | $39.01 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $37.78 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $37.26 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $28.35 | 2024 | |
| Alk-Abello, INC | $24.22 | 2024 | Standardized Mite D. Farinae, Histamine Positive, Timothy, Standardized |
| Lilly USA, LLC | $22.35 | 2024 | Jaypirca |
| Seagen INC. | $21.59 | 2023 | Padcev |
| Smith+Nephew, INC. | $21.50 | 2025 | Halo |
| Cochlear Americas | $19.91 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Intersect Ent, INC. | $18.34 | 2020 | |
| Greer Laboratories, INC. | $17.73 | 2024 | Oralair |
| Sobi, INC | $16.84 | 2024 | |
| Glaxosmithkline, LLC. | $16.67 | 2025 | Nucala |
| Incyte Corporation | $16.31 | 2022 | |
| Stryker Corporation | $14.58 | 2020 | |
| Rigel Pharmaceuticals, INC. | $14.19 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.